AU7625500A - Caspases and apoptosis - Google Patents

Caspases and apoptosis

Info

Publication number
AU7625500A
AU7625500A AU76255/00A AU7625500A AU7625500A AU 7625500 A AU7625500 A AU 7625500A AU 76255/00 A AU76255/00 A AU 76255/00A AU 7625500 A AU7625500 A AU 7625500A AU 7625500 A AU7625500 A AU 7625500A
Authority
AU
Australia
Prior art keywords
caspases
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76255/00A
Inventor
John D. Elliott
John G. Gleason
Dennis Lee
Scott A. Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU7625500A publication Critical patent/AU7625500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU76255/00A 1999-09-30 2000-09-29 Caspases and apoptosis Abandoned AU7625500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15687799P 1999-09-30 1999-09-30
US60156877 1999-09-30
PCT/US2000/027030 WO2001022966A1 (en) 1999-09-30 2000-09-29 Caspases and apoptosis

Publications (1)

Publication Number Publication Date
AU7625500A true AU7625500A (en) 2001-04-30

Family

ID=22561469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76255/00A Abandoned AU7625500A (en) 1999-09-30 2000-09-29 Caspases and apoptosis

Country Status (4)

Country Link
EP (1) EP1242081A4 (en)
JP (1) JP2003510278A (en)
AU (1) AU7625500A (en)
WO (1) WO2001022966A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262711A1 (en) * 2000-06-08 2001-12-17 Mitsubishi Pharma Corporation Cytoprotectors
GB0225938D0 (en) * 2002-11-06 2002-12-11 Glaxo Group Ltd Novel compounds
AU2004218161B9 (en) 2003-03-07 2009-11-26 Kowa Co., Ltd. Benzofuran derivative
AU2005324905B2 (en) * 2005-01-17 2012-01-19 Universitaetsklinikum Muenster 5-pyrrolidinylsulfonyl isatin derivatives
RU2535975C2 (en) 2008-09-05 2014-12-20 Империал Инновейшнз Лимитед Isatin derivatives applicable as imaging in vivo agents
AU2011245441B2 (en) 2010-04-29 2014-12-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
CN103183631B (en) * 2011-12-28 2016-08-24 天津市国际生物医药联合研究院 Isatin-5-sulfonic acid amide derivatives and the application in the medicine of preparation treatment severe acute respiratory syndrome thereof
CN110818619B (en) * 2019-12-13 2021-03-02 山东铂源药业有限公司 Synthetic method of N- (3-chloro-4- (2-pyridylmethoxy) phenyl) -2-cyanoacetamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164404A (en) * 1991-03-15 1992-11-17 Neurosearch A/S Hydrazone derivatives and their use
US5223527A (en) * 1991-07-09 1993-06-29 Neurosearch A/S Isatineoxime derivatives and their use
AR016384A1 (en) * 1997-07-30 2001-07-04 Smithkline Beecham Corp INHIBITORS OF CASPASAS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITORS OF CASPASAS AND USE OF CASPASE INHIBITORS TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF APOPTOSIS AND DISORDERS ASSOCIATED WITH EXCESSIVE ACTIVITY ILL-1 CONVERT.

Also Published As

Publication number Publication date
EP1242081A4 (en) 2004-07-21
EP1242081A1 (en) 2002-09-25
JP2003510278A (en) 2003-03-18
WO2001022966A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3620600A (en) Skin-marking devices and their use
AU5826100A (en) Benzazepinones and quinazolines
AU6800100A (en) Alpha regions
IL132770A0 (en) Caspases and apoptosis
ZA986761B (en) Caspases and apoptosis
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU4576299A (en) Caspases and apoptosis
AU7625500A (en) Caspases and apoptosis
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU6486900A (en) Modulator and integrated circuit
AU1055600A (en) Facilitating ablutions
EP1129108A4 (en) Caspases and apoptosis
AU5762899A (en) Caspase inhibitor
AU2669201A (en) Taccalonolides and their use
AU5979300A (en) Angiopoietin-6 and uses thereof
AU7353500A (en) Apoptosis proteins
AU1901801A (en) Glucofuranoses
AU1414700A (en) Pgt and apoptosis
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
AU1915601A (en) Periotome
AU2582200A (en) Windturbine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase